Chemotherapy-Related Hair Loss (Alopecia)

What to expect, scalp cooling options, and emotional support for hair loss during cancer treatment

Key Points

• Hair loss typically begins 2–4 weeks after the first chemotherapy cycle and is almost always temporary.
• Scalp cooling (cold cap therapy) with FDA-cleared devices (DigniCap, Paxman) can preserve hair in 50–65% of taxane-treated patients.
• Doxorubicin (Adriamycin), cyclophosphamide, paclitaxel, and docetaxel cause the most significant hair loss.
• Hair regrowth typically begins 3–6 months after the last chemotherapy cycle; texture and color may initially differ.
• Insurance may cover a wig as a "cranial prosthesis" — request a letter of medical necessity from your oncologist.
• Look Good Feel Better offers free makeup and wig workshops for patients undergoing cancer treatment.

Why Chemotherapy Causes Hair Loss

Hair loss (alopecia) occurs because chemotherapy targets all rapidly dividing cells in the body — and hair follicles in the active growth phase (anagen) are among the most metabolically active tissues. Approximately 85–90% of scalp follicles are in anagen at any given time, making them highly vulnerable. Chemotherapy disrupts follicle cell division, weakening the hair shaft until it breaks off at the scalp surface. Hair loss typically begins 2–4 weeks after the first chemotherapy cycle, often starting with increased shedding in the shower or on the pillow. Many patients find it helpful to…

Which Drugs Cause the Most Hair Loss

Chemotherapy agents vary widely in their alopecia-inducing potential: Severe/expected alopecia (near-universal when used at standard doses): doxorubicin (Adriamycin), cyclophosphamide, paclitaxel, docetaxel, nab-paclitaxel (Abraxane), ifosfamide, topotecan, and etoposide. The combination regimen AC (doxorubicin + cyclophosphamide) almost invariably causes complete scalp alopecia. Moderate alopecia: carboplatin (alone, less severe; combined with taxane, more severe), vinorelbine, 5-fluorouracil (rare isolated alopecia, more common in combination). Minimal or no alopecia: bevacizumab and most…

Scalp Cooling (Cold Cap Therapy)

Scalp cooling works by applying a cold cap (maintained at approximately -4°C/25°F) to the scalp during chemotherapy infusion. The cold causes local vasoconstriction, reducing blood flow to hair follicles and thereby decreasing the concentration of chemotherapy that reaches them. Cold also reduces follicle metabolic rate, further decreasing vulnerability. Two systems are FDA-cleared in the United States: DigniCap (Dignitana) and Paxman. Both consist of a chilled cap worn before, during, and after infusion. The cold cap must be applied 30–60 minutes before infusion starts and kept on for…

Hair Regrowth After Treatment

Hair regrowth begins in the majority of patients approximately 3–6 months after the last chemotherapy cycle. Initial regrowth is often soft and downy; the "chemo curl" — in which hair grows back with a different texture (often curlier) or color (sometimes darker or slightly different shade) than pre-treatment hair — is common and typically resolves within 6–12 months as hair cycles through additional growth phases. Eyelashes and eyebrows tend to regrow within 3–4 months after completing treatment, often earlier than full scalp hair regrowth. Permanent chemotherapy-induced alopecia (pCIA) is…

Coping and Support

Hair loss is one of the most emotionally significant aspects of chemotherapy for many patients — it is a visible, public announcement of illness and a constant reminder of treatment. Normalizing the grief response to hair loss is important; it is not superficial to feel distress about it. Practical preparation: Consider cutting hair short or shaving before hair begins falling out — this can feel empowering and reduces the distress of seeing large amounts of hair shed. Shop for a wig while you still have your natural hair — this makes it easier to match color and style. Many cancer centers…